Knowledge, Attitude and Practice towards eye pressure disease in established eye pressure disease patients who are on treatment for more than one year.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: H40-H42- Glaucoma
- Registration Number
- CTRI/2024/03/063437
- Lead Sponsor
- Dr Preethi S R
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All glaucoma patients more than 18 years of age, who are on treatment for more than one year.
Exclusion Criteria
nil
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie glaucoma progression in patients on long-term treatment?
How do current drug classes like beta-blockers and prostaglandin analogs compare in managing intraocular pressure for glaucoma patients?
Which biomarkers are most predictive of treatment response and disease progression in chronic glaucoma management?
What adverse events are commonly associated with long-term glaucoma therapies and how can they be mitigated?
Are there emerging combination therapies or novel drug targets being explored for improved glaucoma treatment outcomes?